Teradyne (TER) Financials

$74.07 -1.37 (-1.82%)

Closing price 04:00 PM Eastern

Extended Trading

$73.85 -0.22 (-0.30%)

As of 05:30 PM Eastern

Annual Income Statements for Teradyne

This table shows Teradyne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	206	-43	258	452	467	784	1,015	716	449	542
Consolidated Net Income / (Loss)	206	-43	258	452	467	784	1,015	716	449	542
Net Income / (Loss) Continuing Operations	206	-43	258	452	467	784	1,015	716	449	542
Total Pre-Tax Income	253	-55	524	468	526	901	1,161	840	526	609
Total Operating Income	243	-63	525	474	554	928	1,201	832	501	594
Total Gross Profit	916	959	1,221	1,220	1,340	1,786	2,207	1,867	1,537	1,649
Total Revenue	1,640	1,753	2,137	2,101	2,295	3,121	3,703	3,155	2,676	2,820
Operating Revenue	1,640	1,753	2,137	2,101	2,295	3,121	3,703	3,155	2,676	2,820
Total Cost of Revenue	724	795	915	880	955	1,336	1,496	1,288	1,140	1,171
Operating Cost of Revenue	724	795	915	880	955	1,336	1,496	1,288	1,140	1,171
Total Operating Expenses	673	1,022	696	747	786	857	1,006	1,035	1,036	1,055
Selling, General & Admin Expense	306	317	349	391	437	465	548	558	577	617
Research & Development Expense	292	292	307	302	323	375	428	441	418	461
Amortization Expense	69	53	31	39	40	31	21	19	19	19
Other Operating Expenses / (Income)	-	-	-	-	-	-	-	0.00	0.00	-57
Restructuring Charge	5.08	22	9.36	15	-14	-13	9.31	17	21	16
Total Other Income / (Expense), net	10	7.91	-0.93	-6.00	-28	-27	-40	8.45	25	15
Interest Expense	1.88	3.64	22	22	22	24	18	3.72	3.81	3.59
Interest & Investment Income	7.21	9.30	18	20	17	5.98	2.63	6.38	27	25
Other Income / (Expense), net	4.82	2.25	2.93	-4.67	-23	-9.19	-25	5.79	0.96	-5.89
Income Tax Expense	47	-12	267	16	58	117	146	125	77	60
Other Gains / (Losses), net	-	-	-	-	-	-	-	0.00	0.00	-7.21
Basic Earnings per Share	$0.98	($0.21)	$1.30	$2.41	$2.74	$4.72	$6.15	$4.52	$2.91	$3.41
Weighted Average Basic Shares Outstanding	211.54M	202.58M	198.07M	187.67M	170.43M	166.12M	164.96M	158.43M	154.31M	159.08M
Diluted Earnings per Share	$0.97	($0.21)	$1.28	$2.35	$2.60	$4.28	$5.53	$4.22	$2.73	$3.32
Weighted Average Diluted Shares Outstanding	213.32M	202.58M	201.64M	192.61M	179.46M	183.04M	183.63M	169.73M	164.30M	163.31M
Weighted Average Basic & Diluted Shares Outstanding	210.70M	206.80M	198.20M	173.63M	166.78M	166.69M	162.42M	156.05M	153.08M	161.72M
Cash Dividends to Common per Share	$0.24	$0.24	$0.28	$0.36	$0.09	$0.10	$0.40	$0.44	$0.44	$0.48

This table shows Teradyne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	12/31/2022	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	183	172	84	120	128	117	64	186	146	146
Consolidated Net Income / (Loss)	183	172	84	120	128	117	64	186	146	146
Net Income / (Loss) Continuing Operations	183	172	84	120	128	117	64	186	146	146
Total Pre-Tax Income	226	195	97	144	144	140	73	219	159	158
Total Operating Income	232	167	93	140	144	124	78	210	152	154
Total Gross Profit	485	420	356	402	398	380	339	426	437	447
Total Revenue	827	732	618	684	704	671	600	730	737	753
Operating Revenue	827	732	618	684	704	671	600	730	737	753
Total Cost of Revenue	342	311	261	282	305	291	261	304	301	306
Operating Cost of Revenue	342	311	261	282	305	291	261	304	301	306
Total Operating Expenses	254	254	264	263	254	255	262	215	284	294
Selling, General & Admin Expense	136	143	151	146	138	142	149	154	158	156
Research & Development Expense	112	109	106	106	104	102	103	112	117	128
Amortization Expense	4.73	4.67	4.80	4.83	4.72	4.65	4.70	4.66	4.75	4.66
Restructuring Charge	1.80	-2.37	2.04	6.36	6.86	6.03	4.43	2.01	4.58	4.55
Total Other Income / (Expense), net	-5.31	29	4.22	4.49	0.31	15	-4.87	9.04	6.92	4.21
Interest Expense	0.78	1.02	0.99	1.05	0.96	0.81	0.66	1.53	0.81	0.59
Interest & Investment Income	1.32	3.41	5.26	6.35	6.87	8.86	7.87	6.72	5.08	5.11
Other Income / (Expense), net	-5.85	26	-0.05	-0.82	-5.60	7.43	-12	3.85	2.65	-0.31
Income Tax Expense	43	23	14	24	16	23	8.71	33	12	5.41
Basic Earnings per Share	$1.17	$1.11	$0.54	$0.78	$0.83	$0.76	$0.42	$1.18	$0.89	$0.92
Weighted Average Basic Shares Outstanding	156.36M	158.43M	155.90M	154.76M	153.76M	154.31M	153.05M	157.80M	163.00M	159.08M
Diluted Earnings per Share	$1.10	$1.04	$0.50	$0.73	$0.78	$0.72	$0.40	$1.14	$0.89	$0.89
Weighted Average Diluted Shares Outstanding	166.73M	169.73M	166.31M	164.75M	164.05M	164.30M	162.35M	163.47M	164.25M	163.31M
Weighted Average Basic & Diluted Shares Outstanding	155.76M	156.05M	155.04M	154.01M	152.88M	153.08M	156.11M	163.18M	162.86M	161.72M

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-30	43	122	497	-153	140	208	-267	-97	-204
Net Cash From Operating Activities	423	455	626	477	579	869	1,098	578	585	672
Net Cash From Continuing Operating Activities	423	455	626	477	579	869	1,098	578	585	672
Net Income / (Loss) Continuing Operations	206	-43	258	452	467	784	1,015	716	449	542
Consolidated Net Income / (Loss)	206	-43	258	452	467	784	1,015	716	449	542
Depreciation Expense	68	65	66	67	71	80	91	91	92	101
Amortization Expense	90	52	35	42	50	57	34	-5.67	19	14
Non-Cash Adjustments To Reconcile Net Income	43	380	39	49	71	56	82	89	73	37
Changes in Operating Assets and Liabilities, net	15	1.93	228	-134	-80	-108	-123	-311	-47	-22
Net Cash From Investing Activities	-114	-640	-263	923	-157	-570	120	44	-180	-622
Net Cash From Continuing Investing Activities	-114	-640	-263	923	-157	-570	120	44	-180	-622
Purchase of Property, Plant & Equipment	-90	-85	-105	-114	-135	-185	-132	-163	-160	-730
Purchase of Investments	-1,424	-1,656	-1,392	-919	-663	-900	-662	-287	-162	-46
Sale of Property, Plant & Equipment	-	-	-	-	-	0.00	0.00	3.41	0.00	0.00
Divestitures	-	-	-	-	-	-	-	0.00	0.00	90
Sale and/or Maturity of Investments	1,676	1,096	1,229	2,117	718	515	927	491	146	62
Other Investing Activities, net	6.50	5.05	5.06	9.05	2.91	0.55	0.00	0.00	-4.54	0.87
Net Cash From Financing Activities	-339	228	-245	-903	-574	-158	-1,009	-893	-502	-252
Net Cash From Continuing Financing Activities	-339	228	-245	-903	-574	-158	-1,009	-893	-502	-252
Repayment of Debt	-2.25	-	-	-	0.00	0.00	-343	-67	-50	-185
Repurchase of Common Equity	-300	-146	-200	-823	-500	-88	-600	-752	-397	-199
Payment of Dividends	-51	-49	-55	-67	-61	-66	-66	-70	-68	-76
Issuance of Debt	-	451	-	-	-	-	-	0.00	0.00	185
Issuance of Common Equity	20	88	24	21	29	29	33	29	34	37
Other Financing Activities, net	-5.52	-116	-14	-34	-42	-32	-32	-33	-21	-14
Other Net Changes in Cash	-	-	-	-	-	-0.66	-	3.89	-	-2.28
Cash Interest Paid	0.30	0.45	6.45	6.21	6.00	6.44	4.24	1.50	0.30	0.77
Cash Income Taxes Paid	35	40	54	73	81	107	172	193	140	121

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	12/31/2022	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024
Net Change in Cash & Equivalents	139	144	-206	-36	24	121	-50	-285	88	43
Net Cash From Operating Activities	272	183	19	143	174	249	7.28	216	166	283
Net Cash From Continuing Operating Activities	272	183	19	143	174	249	7.28	216	166	283
Net Income / (Loss) Continuing Operations	183	172	84	120	128	117	64	186	146	146
Consolidated Net Income / (Loss)	183	172	84	120	128	117	64	186	146	146
Depreciation Expense	23	23	23	23	24	23	23	26	26	26
Amortization Expense	4.92	-21	4.93	4.65	4.50	4.69	4.77	4.38	4.99	0.28
Non-Cash Adjustments To Reconcile Net Income	27	20	22	17	26	7.74	33	-36	9.98	30
Changes in Operating Assets and Liabilities, net	33	-11	-114	-21	-8.08	96	-118	36	-20	80
Net Cash From Investing Activities	100	-1.69	-95	-27	-28	-30	-24	-481	-50	-67
Net Cash From Continuing Investing Activities	100	-1.69	-95	-27	-28	-30	-24	-481	-50	-67
Purchase of Property, Plant & Equipment	-39	-35	-41	-39	-35	-44	-44	-569	-54	-62
Purchase of Investments	-19	-20	-69	-30	-39	-24	-16	-12	-7.34	-11
Sale and/or Maturity of Investments	158	50	15	42	51	38	35	13	8.62	5.63
Net Cash From Financing Activities	-232	-34	-130	-154	-128	-91	-37	-23	-29	-163
Net Cash From Continuing Financing Activities	-232	-34	-130	-154	-128	-91	-37	-23	-29	-163
Repurchase of Common Equity	-217	-2.08	-93	-135	-119	-51	-22	-8.19	-25	-144
Payment of Dividends	-17	-17	-17	-17	-17	-17	-18	-19	-20	-19
Issuance of Common Equity	12	-	16	0.60	17	0.18	17	4.90	15	0.07
Other Financing Activities, net	-0.21	-0.18	-20	-0.44	-0.28	-0.20	-13	-0.32	-0.40	-0.27

This table presents Teradyne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,549	2,762	3,110	2,707	2,787	3,652	3,809	3,501	3,487	3,709
Total Current Assets	1,260	1,624	2,270	1,732	1,659	2,415	2,576	2,258	2,162	1,816
Cash & Equivalents	265	308	430	927	774	914	1,122	855	758	553
Short-Term Investments	478	871	1,348	190	137	522	244	40	62	46
Accounts Receivable	211	192	273	291	362	498	551	491	422	471
Inventories, net	154	136	108	154	197	222	243	325	310	298
Prepaid Expenses	92	116	112	171	189	250	406	533	549	429
Other Current Assets	6.19	-	-	-	-	9.25	9.45	14	38	18
Other Current Nonoperating Assets	-	-	-	-	-	-	-	0.00	23	0.00
Plant, Property, & Equipment, net	273	254	268	280	320	395	387	419	445	508
Total Noncurrent Assets	1,015	885	571	694	808	842	846	825	879	1,384
Long-Term Investments	266	434	126	88	104	118	134	111	117	619
Goodwill	488	223	252	382	416	454	426	403	416	395
Intangible Assets	240	100	79	125	125	101	76	53	35	16
Noncurrent Deferred & Refundable Income Taxes	7.40	107	84	71	75	88	102	143	176	222
Employee Benefit Assets	0.64	7.71	17	17	18	17	15	12	12	12
Other Noncurrent Operating Assets	13	12	12	12	68	64	93	103	112	120
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	0.00	12	0.00
Total Liabilities & Shareholders' Equity	2,549	2,762	3,110	2,707	2,787	3,652	3,809	3,501	3,487	3,709
Total Liabilities	583	934	1,156	1,184	1,307	1,442	1,245	1,050	961	889
Total Current Liabilities	373	373	454	476	539	701	805	746	660	625
Accounts Payable	92	95	86	101	127	134	153	140	180	135
Accrued Expenses	44	51	59	78	71	78	124	112	115	91
Current Deferred Revenue	86	84	84	78	105	135	146	148	100	108
Current Deferred & Payable Income Tax Liabilities	22	30	59	36	44	81	89	65	49	68
Current Employee Benefit Liabilities	114	110	142	149	164	220	254	212	192	205
Other Current Liabilities	-	-	-	-	19	21	20	19	18	19
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	7.38	0.00
Total Noncurrent Liabilities	210	561	702	708	768	741	440	304	301	265
Long-Term Debt	-	353	366	380	395	377	89	0.00	0.00	0.00
Noncurrent Deferred Revenue	26	23	178	117	129	133	122	104	82	65
Noncurrent Deferred & Payable Income Tax Liabilities	27	12	6.72	21	14	11	6.33	3.27	0.18	1.04
Noncurrent Employee Benefit Liabilities	104	107	120	117	134	151	151	116	132	133
Other Noncurrent Operating Liabilities	54	66	31	73	96	69	72	80	85	65
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	2.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819
Total Preferred & Common Equity	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819
Total Common Equity	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819
Common Stock	1,506	1,619	1,663	1,694	1,741	1,786	1,832	1,775	1,846	1,930
Retained Earnings	468	230	272	-158	-242	387	737	726	707	971
Accumulated Other Comprehensive Income / (Loss)	-8.14	-20	19	-13	-19	34	-5.95	-50	-27	-81

This table presents Teradyne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	12/31/2022	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024
Total Assets	3,320	3,501	3,383	3,395	3,371	3,487	3,411	3,632	3,770	3,709
Total Current Assets	2,128	2,258	2,112	2,124	2,099	2,162	2,065	1,756	1,839	1,816
Cash & Equivalents	711	855	649	613	637	758	707	422	510	553
Short-Term Investments	65	40	93	95	80	62	41	39	42	46
Accounts Receivable	530	491	455	493	456	422	426	470	484	471
Inventories, net	311	325	352	347	323	310	314	289	297	298
Prepaid Expenses	503	533	549	561	593	549	538	516	490	429
Other Current Assets	7.72	14	13	14	11	38	16	21	16	18
Other Current Nonoperating Assets	-	0.00	-	-	-	23	22	0.00	0.00	0.00
Plant, Property, & Equipment, net	415	419	432	437	436	445	457	472	492	508
Total Noncurrent Assets	777	825	839	834	835	879	888	1,403	1,439	1,384
Long-Term Investments	111	111	117	105	104	117	122	648	664	619
Goodwill	376	403	410	412	401	416	408	405	419	395
Intangible Assets	56	53	49	45	39	35	30	25	21	16
Noncurrent Deferred & Refundable Income Taxes	130	143	149	152	163	176	186	193	202	222
Employee Benefit Assets	14	12	12	12	11	12	11	11	13	12
Other Noncurrent Operating Assets	91	103	103	109	117	112	120	120	119	120
Other Noncurrent Nonoperating Assets	-	0.00	-	-	-	12	11	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	3,320	3,501	3,383	3,395	3,371	3,487	3,411	3,632	3,770	3,709
Total Liabilities	1,066	1,050	934	960	929	961	853	901	867	889
Total Current Liabilities	702	746	628	670	641	660	554	626	595	625
Accounts Payable	168	140	142	153	176	180	154	161	158	135
Accrued Expenses	126	112	115	114	123	115	101	109	105	91
Current Deferred Revenue	144	148	119	120	109	100	100	103	100	108
Current Deferred & Payable Income Tax Liabilities	64	65	77	65	36	49	56	74	53	68
Current Employee Benefit Liabilities	168	212	119	164	155	192	121	161	160	205
Other Current Liabilities	17	19	20	20	18	18	17	18	19	19
Other Current Nonoperating Liabilities	-	0.00	-	-	-	7.38	4.69	0.00	0.00	0.00
Total Noncurrent Liabilities	364	304	306	290	289	301	299	275	272	265
Long-Term Debt	50	0.00	-	-	-	0.00	-	-	-	0.00
Noncurrent Deferred Revenue	108	104	101	83	79	82	79	61	66	65
Noncurrent Deferred & Payable Income Tax Liabilities	1.33	3.27	2.33	1.30	0.24	0.18	0.13	0.10	0.16	1.04
Noncurrent Employee Benefit Liabilities	137	116	121	124	123	132	135	135	138	133
Other Noncurrent Operating Liabilities	67	80	81	82	86	85	82	79	69	65
Other Noncurrent Nonoperating Liabilities	-	0.00	-	-	-	2.00	1.94	0.00	0.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,254	2,451	2,449	2,435	2,441	2,526	2,558	2,731	2,903	2,819
Total Preferred & Common Equity	2,254	2,451	2,449	2,435	2,441	2,526	2,558	2,731	2,903	2,819
Total Common Equity	2,254	2,451	2,449	2,435	2,441	2,526	2,558	2,731	2,903	2,819
Common Stock	1,766	1,775	1,792	1,804	1,835	1,846	1,867	1,886	1,917	1,930
Retained Earnings	573	726	694	661	654	707	730	889	990	971
Accumulated Other Comprehensive Income / (Loss)	-85	-50	-36	-30	-48	-27	-40	-44	-4.03	-81

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.50%	6.93%	21.87%	-1.68%	9.24%	36.01%	18.63%	-14.79%	-15.17%	5.36%
EBITDA Growth	37.65%	-86.20%	1,022.76%	-8.05%	12.54%	62.08%	23.23%	-29.10%	-33.58%	14.74%
EBIT Growth	157.97%	-124.50%	970.02%	-11.20%	13.19%	73.11%	27.95%	-28.77%	-40.07%	17.10%
NOPAT Growth	141.22%	-122.24%	685.65%	77.25%	7.58%	64.14%	29.87%	-32.50%	-39.60%	25.23%
Net Income Growth	154.06%	-121.03%	693.47%	75.32%	3.47%	67.74%	29.39%	-29.48%	-37.28%	20.86%
EPS Growth	162.16%	-121.65%	709.52%	83.59%	10.64%	64.62%	29.21%	-23.69%	-35.31%	21.61%
Operating Cash Flow Growth	-14.02%	7.59%	37.63%	-23.88%	21.36%	50.14%	26.40%	-47.38%	1.26%	14.86%
Free Cash Flow Firm Growth	-97.70%	5,621.09%	7.83%	-57.32%	115.72%	70.95%	54.80%	-59.30%	-6.10%	38.08%
Invested Capital Growth	24.57%	-41.45%	-22.69%	66.36%	18.51%	22.84%	9.90%	27.66%	4.48%	2.41%
Revenue Q/Q Growth	-0.29%	3.64%	4.88%	1.95%	6.25%	3.46%	3.52%	-4.63%	-2.24%	3.01%
EBITDA Q/Q Growth	26.92%	193.57%	6.55%	3.48%	7.26%	8.78%	1.52%	-9.13%	-9.04%	2.98%
EBIT Q/Q Growth	88.77%	52.65%	8.10%	3.30%	7.96%	9.19%	2.49%	-7.12%	-10.85%	3.80%
NOPAT Q/Q Growth	107.95%	51.16%	-40.17%	125.75%	-0.03%	8.23%	1.85%	-9.83%	-9.23%	9.09%
Net Income Q/Q Growth	99.87%	60.67%	-40.07%	123.58%	-3.85%	10.00%	2.81%	-6.74%	-10.96%	5.69%
EPS Q/Q Growth	97.96%	61.82%	-40.47%	123.81%	-3.35%	9.46%	4.14%	-5.17%	-10.49%	5.40%
Operating Cash Flow Q/Q Growth	-22.73%	-2.83%	21.35%	8.88%	5.46%	5.35%	6.90%	-20.37%	12.58%	5.29%
Free Cash Flow Firm Q/Q Growth	-95.36%	2.88%	23.13%	77.30%	-12.56%	15.50%	10.65%	-34.84%	39.42%	10.95%
Invested Capital Q/Q Growth	0.47%	7.68%	-31.81%	-3.00%	3.38%	0.76%	-5.16%	4.50%	-4.93%	-5.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.85%	54.68%	57.17%	58.09%	58.38%	57.21%	59.59%	59.18%	57.42%	58.48%
EBITDA Margin	24.78%	3.20%	29.47%	27.56%	28.40%	33.84%	35.15%	29.25%	22.90%	24.94%
Operating Margin	14.82%	-3.59%	24.59%	22.55%	24.12%	29.74%	32.43%	26.37%	18.72%	21.06%
EBIT Margin	15.11%	-3.46%	24.72%	22.33%	23.14%	29.45%	31.76%	26.55%	18.76%	20.85%
Profit (Net Income) Margin	12.59%	-2.48%	12.06%	21.51%	20.37%	25.12%	27.40%	22.68%	16.77%	19.23%
Tax Burden Percent	81.57%	78.86%	49.14%	96.58%	88.91%	87.03%	87.39%	85.14%	85.38%	89.05%
Interest Burden Percent	102.15%	90.68%	99.27%	99.72%	99.01%	98.02%	98.71%	100.32%	104.69%	103.60%
Effective Tax Rate	18.43%	0.00%	50.86%	3.43%	11.09%	12.97%	12.61%	14.86%	14.62%	9.77%
Return on Invested Capital (ROIC)	22.60%	-5.72%	51.12%	78.02%	61.50%	83.52%	93.75%	53.09%	27.97%	33.86%
ROIC Less NNEP Spread (ROIC-NNEP)	21.88%	-5.77%	51.15%	78.52%	65.04%	86.24%	96.49%	52.48%	25.78%	33.26%
Return on Net Nonoperating Assets (RNNOA)	-12.39%	3.43%	-37.49%	-52.02%	-30.36%	-41.03%	-51.25%	-24.56%	-9.93%	-13.57%
Return on Equity (ROE)	10.21%	-2.29%	13.63%	25.99%	31.14%	42.49%	42.50%	28.53%	18.03%	20.29%
Cash Return on Invested Capital (CROIC)	0.72%	46.58%	76.71%	28.19%	44.56%	63.02%	84.32%	28.79%	23.58%	31.48%
Operating Return on Assets (OROA)	9.74%	-2.29%	17.99%	16.13%	19.33%	28.55%	31.52%	22.92%	14.37%	16.34%
Return on Assets (ROA)	8.12%	-1.64%	8.78%	15.54%	17.02%	24.35%	27.19%	19.57%	12.84%	15.08%
Return on Common Equity (ROCE)	10.21%	-2.29%	13.63%	25.99%	31.14%	42.45%	42.45%	28.52%	18.03%	20.29%
Return on Equity Simple (ROE_SIMPLE)	10.50%	-2.37%	13.19%	29.68%	31.58%	35.53%	39.59%	29.19%	17.77%	19.24%
Net Operating Profit after Tax (NOPAT)	198	-44	258	458	492	808	1,049	708	428	536
NOPAT Margin	12.09%	-2.51%	12.08%	21.78%	21.45%	25.88%	28.34%	22.45%	15.99%	19.00%
Net Nonoperating Expense Percent (NNEP)	0.72%	0.06%	-0.03%	-0.50%	-3.54%	-2.71%	-2.74%	0.61%	2.18%	0.60%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	28.32%	16.94%	19.00%
Cost of Revenue to Revenue	44.15%	45.32%	42.83%	41.91%	41.62%	42.79%	40.41%	40.82%	42.58%	41.52%
SG&A Expenses to Revenue	18.68%	18.05%	16.33%	18.60%	19.05%	14.89%	14.79%	17.69%	21.57%	21.88%
R&D to Revenue	17.82%	16.66%	14.38%	14.35%	14.07%	12.01%	11.55%	13.96%	15.62%	16.34%
Operating Expenses to Revenue	41.03%	58.27%	32.58%	35.54%	34.26%	27.47%	27.17%	32.81%	38.70%	37.42%
Earnings before Interest and Taxes (EBIT)	248	-61	528	469	531	919	1,176	838	502	588
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	406	56	630	579	652	1,056	1,302	923	613	703
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.05	2.68	4.06	3.60	7.58	8.90	10.29	5.50	6.53	7.27
Price to Tangible Book Value (P/TBV)	3.25	3.25	4.89	5.40	11.95	11.88	12.80	6.76	7.95	8.51
Price to Revenue (P/Rev)	2.45	2.79	3.71	2.61	4.89	6.29	7.12	4.27	6.17	7.26
Price to Earnings (P/E)	19.47	0.00	30.76	12.13	23.99	25.04	25.99	18.83	36.78	37.77
Dividend Yield	1.23%	0.99%	0.69%	1.18%	0.54%	0.34%	0.25%	0.51%	0.41%	0.38%
Earnings Yield	5.13%	0.00%	3.25%	8.25%	4.17%	3.99%	3.85%	5.31%	2.72%	2.65%
Enterprise Value to Invested Capital (EV/IC)	3.11	6.38	14.56	6.40	12.21	17.34	21.31	8.37	9.96	12.03
Enterprise Value to Revenue (EV/Rev)	1.85	2.07	3.00	2.23	4.62	5.93	6.75	3.97	5.82	6.83
Enterprise Value to EBITDA (EV/EBITDA)	7.45	64.81	10.19	8.10	16.27	17.51	19.19	13.57	25.40	27.40
Enterprise Value to EBIT (EV/EBIT)	12.22	0.00	12.14	9.99	19.96	20.12	21.24	14.95	31.01	32.77
Enterprise Value to NOPAT (EV/NOPAT)	15.28	0.00	24.85	10.25	21.53	22.89	23.80	17.68	36.39	35.96
Enterprise Value to Operating Cash Flow (EV/OCF)	7.16	7.99	10.24	9.83	18.32	21.28	22.74	21.67	26.60	28.66
Enterprise Value to Free Cash Flow (EV/FCFF)	482.24	10.12	16.56	28.36	29.72	30.34	26.47	32.59	43.16	38.68
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.19	0.20	0.27	0.27	0.19	0.04	0.02	0.00	0.00
Long-Term Debt to Equity	0.00	0.19	0.19	0.25	0.27	0.17	0.03	0.00	0.00	0.00
Financial Leverage	-0.57	-0.59	-0.73	-0.66	-0.47	-0.48	-0.53	-0.47	-0.39	-0.41
Leverage Ratio	1.26	1.40	1.55	1.67	1.83	1.74	1.56	1.46	1.40	1.35
Compound Leverage Factor	1.28	1.27	1.54	1.67	1.81	1.71	1.54	1.46	1.47	1.39
Debt to Total Capital	0.78%	16.21%	16.66%	21.41%	21.43%	15.65%	4.06%	2.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.78%	0.05%	1.05%	1.80%	0.48%	1.27%	0.72%	2.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	16.16%	15.61%	19.62%	20.95%	14.38%	3.34%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.14%	0.06%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.22%	83.79%	83.34%	78.59%	78.57%	84.21%	95.89%	98.00%	100.00%	100.00%
Debt to EBITDA	0.04	6.31	0.62	0.72	0.62	0.39	0.08	0.05	0.00	0.00
Net Debt to EBITDA	-2.44	-22.45	-2.40	-1.36	-0.94	-1.08	-1.07	-1.03	0.00	0.00
Long-Term Debt to EBITDA	0.00	6.29	0.58	0.66	0.61	0.36	0.07	0.00	0.00	0.00
Debt to NOPAT	0.08	-8.02	1.51	0.91	0.82	0.51	0.10	0.07	0.00	0.00
Net Debt to NOPAT	-5.01	28.56	-5.86	-1.73	-1.24	-1.42	-1.33	-1.35	0.00	0.00
Long-Term Debt to NOPAT	0.00	-8.00	1.42	0.83	0.80	0.47	0.09	0.00	0.00	0.00
Altman Z-Score	5.78	4.37	6.19	4.60	6.96	10.57	15.52	10.20	12.35	15.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.11%	0.03%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.38	4.36	5.00	3.64	3.08	3.45	3.20	3.03	3.28	2.91
Quick Ratio	2.56	3.68	4.51	2.96	2.36	2.76	2.38	1.86	1.88	1.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.28	359	387	165	357	610	944	384	361	498
Operating Cash Flow to CapEx	470.72%	533.82%	594.54%	416.93%	429.84%	469.75%	829.13%	361.57%	366.59%	92.06%
Free Cash Flow to Firm to Interest Expense	3.35	98.78	17.88	7.59	16.05	25.21	52.96	103.30	94.78	138.86
Operating Cash Flow to Interest Expense	225.52	125.16	28.92	21.90	26.04	35.93	61.64	155.40	153.77	187.39
Operating Cash Flow Less CapEx to Interest Expense	177.61	101.71	24.06	16.64	19.98	28.28	54.20	112.42	111.82	-16.16
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.64	0.66	0.73	0.72	0.84	0.97	0.99	0.86	0.77	0.78
Accounts Receivable Turnover	9.05	8.69	9.19	7.45	7.02	7.26	7.06	6.06	5.86	6.31
Inventory Turnover	5.60	5.49	7.52	6.74	5.45	6.38	6.43	4.53	3.59	3.85
Fixed Asset Turnover	5.44	6.65	8.18	7.66	7.65	8.73	9.47	7.83	6.19	5.91
Accounts Payable Turnover	10.33	8.47	10.07	9.41	8.40	10.26	10.43	8.80	7.13	7.44
Days Sales Outstanding (DSO)	40.33	42.03	39.74	49.00	51.98	50.27	51.66	60.27	62.28	57.83
Days Inventory Outstanding (DIO)	65.22	66.50	48.56	54.12	66.92	57.23	56.78	80.54	101.69	94.83
Days Payable Outstanding (DPO)	35.32	43.11	36.25	38.78	43.43	35.56	34.98	41.50	51.22	49.08
Cash Conversion Cycle (CCC)	70.23	65.41	52.05	64.34	75.47	71.94	73.46	99.31	112.75	103.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	973	570	440	733	868	1,067	1,172	1,496	1,563	1,601
Invested Capital Turnover	1.87	2.27	4.23	3.58	2.87	3.23	3.31	2.36	1.75	1.78
Increase / (Decrease) in Invested Capital	192	-403	-129	292	136	198	106	324	67	38
Enterprise Value (EV)	3,028	3,635	6,414	4,688	10,601	18,495	24,979	12,521	15,568	19,267
Market Capitalization	4,021	4,894	7,927	5,478	11,212	19,636	26,369	13,476	16,505	20,486
Book Value per Share	$9.57	$9.09	$9.96	$8.49	$8.83	$13.29	$15.72	$15.74	$16.52	$17.31
Tangible Book Value per Share	$6.02	$7.48	$8.27	$5.66	$5.60	$9.95	$12.64	$12.81	$13.57	$14.79
Total Capital	1,981	2,182	2,344	1,937	1,884	2,621	2,672	2,501	2,526	2,819
Total Debt	16	354	390	415	404	410	108	50	0.00	0.00
Total Long-Term Debt	0.00	353	366	380	395	377	89	0.00	0.00	0.00
Net Debt	-993	-1,259	-1,513	-790	-612	-1,144	-1,392	-955	-937	-1,218
Capital Expenditures (CapEx)	90	85	105	114	135	185	132	160	160	730
Debt-free, Cash-free Net Working Capital (DFCFNWC)	160	73	63	174	218	312	424	667	682	592
Debt-free Net Working Capital (DFNWC)	903	1,252	1,840	1,291	1,129	1,748	1,790	1,562	1,502	1,192
Net Working Capital (NWC)	887	1,251	1,816	1,256	1,120	1,715	1,771	1,512	1,502	1,192
Net Nonoperating Expense (NNE)	-8.28	-0.66	0.46	5.79	25	24	35	-7.19	-21	-6.59
Net Nonoperating Obligations (NNO)	-993	-1,259	-1,513	-790	-612	-1,144	-1,392	-955	-963	-1,218
Total Depreciation and Amortization (D&A)	159	117	101	110	121	137	125	85	111	115
Debt-free, Cash-free Net Working Capital to Revenue	9.77%	4.18%	2.93%	8.29%	9.49%	9.98%	11.45%	21.15%	25.50%	21.00%
Debt-free Net Working Capital to Revenue	55.05%	71.42%	86.14%	61.46%	49.19%	56.00%	48.35%	49.50%	56.13%	42.26%
Net Working Capital to Revenue	54.11%	71.36%	84.99%	59.80%	48.80%	54.93%	47.83%	47.91%	56.13%	42.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.98	($0.21)	$1.30	$2.41	$2.74	$4.72	$6.15	$4.52	$2.91	$3.41
Adjusted Weighted Average Basic Shares Outstanding	211.54M	202.58M	198.07M	187.67M	170.43M	166.12M	164.96M	158.43M	154.31M	159.08M
Adjusted Diluted Earnings per Share	$0.97	($0.21)	$1.28	$2.35	$2.60	$4.28	$5.53	$4.22	$2.73	$3.32
Adjusted Weighted Average Diluted Shares Outstanding	213.32M	202.58M	201.64M	192.61M	179.46M	183.04M	183.63M	169.73M	164.30M	163.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$2.74	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	204.34M	200.30M	195.42M	173.63M	166.78M	166.69M	162.42M	156.05M	153.08M	161.72M
Normalized Net Operating Profit after Tax (NOPAT)	202	208	374	472	480	796	1,057	723	446	550
Normalized NOPAT Margin	12.34%	11.87%	17.52%	22.48%	20.91%	25.52%	28.56%	22.91%	16.66%	19.50%
Pre Tax Income Margin	15.44%	-3.14%	24.54%	22.27%	22.91%	28.87%	31.35%	26.64%	19.64%	21.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	132.08	-16.69	24.39	21.54	23.89	38.01	66.00	225.26	131.90	163.90
NOPAT to Interest Expense	105.65	-12.12	11.92	21.01	22.15	33.41	58.89	190.46	112.41	149.37
EBIT Less CapEx to Interest Expense	84.17	-40.14	19.52	16.29	17.84	30.36	58.57	182.28	89.96	-39.66
NOPAT Less CapEx to Interest Expense	57.74	-35.57	7.05	15.76	16.09	25.76	51.45	147.48	70.46	-54.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	24.56%	-111.97%	21.52%	14.90%	13.11%	8.48%	6.50%	9.74%	15.13%	14.09%
Augmented Payout Ratio	169.83%	-448.98%	99.25%	197.18%	120.07%	19.76%	65.64%	114.86%	103.65%	50.70%

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	10/2/2022	12/31/2022	4/2/2023	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.99%	-17.31%	-18.25%	-18.59%	-14.91%	-8.37%	-2.87%	6.64%	4.77%	12.27%
EBITDA Growth	-23.31%	-32.21%	-42.22%	-37.33%	-34.45%	-18.11%	-22.09%	46.83%	11.26%	12.74%
EBIT Growth	-25.01%	-24.99%	-48.63%	-41.69%	-38.68%	-31.68%	-29.22%	54.01%	11.81%	16.33%
NOPAT Growth	-32.44%	-34.70%	-52.12%	-43.42%	-31.92%	-29.20%	-14.29%	53.55%	9.77%	42.49%
Net Income Growth	-28.53%	-23.09%	-48.41%	-39.30%	-30.18%	-32.06%	-23.15%	55.16%	13.69%	24.94%
EPS Growth	-21.99%	-18.11%	-45.65%	-37.07%	-29.09%	-30.77%	-20.00%	56.16%	14.10%	23.61%
Operating Cash Flow Growth	-48.03%	-44.64%	159.13%	23.66%	-35.81%	35.65%	-62.36%	51.34%	-4.63%	13.58%
Free Cash Flow Firm Growth	-108.12%	-248.13%	-362.25%	-132.79%	-937.43%	120.89%	119.13%	456.40%	215.84%	199.01%
Invested Capital Growth	15.86%	27.66%	18.86%	11.86%	14.85%	4.48%	2.12%	-1.94%	2.57%	2.41%
Revenue Q/Q Growth	-1.63%	-11.51%	-15.62%	10.83%	2.82%	-4.71%	-10.55%	21.68%	1.02%	2.11%
EBITDA Q/Q Growth	-4.28%	-23.22%	-45.41%	38.10%	0.12%	-4.08%	-41.25%	160.27%	-24.13%	-2.81%
EBIT Q/Q Growth	-5.41%	-14.54%	-51.87%	49.86%	-0.52%	-4.78%	-50.14%	226.07%	-27.78%	-0.93%
NOPAT Q/Q Growth	-8.65%	-21.71%	-45.65%	45.57%	9.91%	-18.58%	-34.21%	160.79%	-21.42%	5.69%
Net Income Q/Q Growth	-7.23%	-6.10%	-51.52%	43.72%	6.72%	-8.63%	-45.16%	190.16%	-21.81%	0.41%
EPS Q/Q Growth	-5.17%	-5.45%	-51.92%	46.00%	6.85%	-7.69%	-44.44%	185.00%	-21.93%	0.00%
Operating Cash Flow Q/Q Growth	135.25%	-32.47%	-89.46%	638.35%	22.12%	42.69%	-97.07%	2,868.39%	-23.05%	69.94%
Free Cash Flow Firm Q/Q Growth	-104.53%	-2,069.01%	-0.47%	66.78%	-43.29%	143.68%	-7.97%	518.83%	-53.43%	12.73%
Invested Capital Q/Q Growth	-3.20%	4.50%	8.64%	1.79%	-0.62%	-4.93%	6.18%	-2.26%	3.95%	-5.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.69%	57.45%	57.72%	58.81%	56.60%	56.60%	56.56%	58.34%	59.20%	59.41%
EBITDA Margin	30.71%	26.65%	19.50%	24.30%	23.66%	23.81%	15.64%	33.45%	25.13%	23.91%
Operating Margin	27.99%	22.76%	15.04%	20.44%	20.46%	18.54%	12.97%	28.82%	20.62%	20.40%
EBIT Margin	27.28%	26.35%	15.03%	20.32%	19.66%	19.65%	10.95%	29.35%	20.98%	20.36%
Profit (Net Income) Margin	22.18%	23.54%	13.53%	17.54%	18.21%	17.46%	10.70%	25.52%	19.75%	19.43%
Tax Burden Percent	81.12%	88.25%	86.04%	83.14%	88.80%	83.73%	88.06%	84.90%	91.61%	92.68%
Interest Burden Percent	100.24%	101.24%	104.60%	103.82%	104.27%	106.11%	110.97%	102.42%	102.76%	102.95%
Effective Tax Rate	18.88%	11.75%	13.96%	16.86%	11.20%	16.27%	11.94%	15.10%	7.71%	3.43%
Return on Invested Capital (ROIC)	56.32%	47.51%	26.09%	31.03%	32.33%	27.16%	18.48%	40.38%	31.29%	35.11%
ROIC Less NNEP Spread (ROIC-NNEP)	56.72%	45.35%	25.71%	30.56%	32.30%	25.80%	18.98%	39.57%	30.76%	35.30%
Return on Net Nonoperating Assets (RNNOA)	-25.16%	-21.22%	-10.08%	-10.33%	-11.14%	-9.94%	-6.53%	-14.47%	-11.59%	-14.40%
Return on Equity (ROE)	31.15%	26.28%	16.00%	20.70%	21.19%	17.21%	11.95%	25.92%	19.70%	20.71%
Cash Return on Invested Capital (CROIC)	44.20%	28.79%	24.32%	22.78%	16.82%	23.58%	23.24%	31.16%	26.96%	31.48%
Operating Return on Assets (OROA)	25.49%	22.74%	12.97%	16.89%	16.09%	15.05%	8.57%	22.59%	16.09%	15.96%
Return on Assets (ROA)	20.73%	20.32%	11.67%	14.58%	14.90%	13.37%	8.38%	19.64%	15.15%	15.23%
Return on Common Equity (ROCE)	31.14%	26.28%	16.00%	20.70%	21.19%	17.21%	11.95%	25.92%	19.70%	20.71%
Return on Equity Simple (ROE_SIMPLE)	34.04%	0.00%	26.01%	22.97%	20.64%	0.00%	16.79%	18.15%	17.68%	0.00%
Net Operating Profit after Tax (NOPAT)	188	147	80	116	128	104	68	179	140	148
NOPAT Margin	22.71%	20.09%	12.94%	16.99%	18.17%	15.52%	11.42%	24.47%	19.03%	19.70%
Net Nonoperating Expense Percent (NNEP)	-0.41%	2.15%	0.38%	0.47%	0.03%	1.35%	-0.50%	0.81%	0.53%	-0.19%
Return On Investment Capital (ROIC_SIMPLE)	-	5.88%	-	-	-	4.12%	-	-	-	5.26%
Cost of Revenue to Revenue	41.31%	42.55%	42.28%	41.19%	43.40%	43.40%	43.44%	41.66%	40.80%	40.59%
SG&A Expenses to Revenue	16.40%	19.51%	24.45%	21.29%	19.66%	21.23%	24.87%	21.16%	21.38%	20.69%
R&D to Revenue	13.51%	14.87%	17.13%	15.44%	14.84%	15.24%	17.21%	15.32%	15.93%	17.05%
Operating Expenses to Revenue	30.70%	34.69%	42.68%	38.37%	36.14%	38.06%	43.60%	29.52%	38.58%	39.01%
Earnings before Interest and Taxes (EBIT)	226	193	93	139	138	132	66	214	155	153
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	254	195	120	166	167	160	94	244	185	180
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.19	5.50	6.81	7.06	6.31	6.53	6.74	8.48	7.57	7.27
Price to Tangible Book Value (P/TBV)	6.42	6.76	8.38	8.69	7.70	7.95	8.13	10.06	8.92	8.51
Price to Revenue (P/Rev)	3.53	4.27	5.53	6.01	5.63	6.17	6.48	8.56	8.03	7.26
Price to Earnings (P/E)	15.24	18.83	26.19	30.73	30.57	36.78	40.13	46.71	42.81	37.77
Dividend Yield	0.58%	0.51%	0.41%	0.40%	0.44%	0.41%	0.40%	0.31%	0.35%	0.38%
Earnings Yield	6.56%	5.31%	3.82%	3.25%	3.27%	2.72%	2.49%	2.14%	2.34%	2.65%
Enterprise Value to Invested Capital (EV/IC)	7.59	8.37	9.76	9.92	8.89	9.96	9.86	13.59	12.31	12.03
Enterprise Value to Revenue (EV/Rev)	3.29	3.97	5.26	5.73	5.34	5.82	6.16	8.15	7.58	6.83
Enterprise Value to EBITDA (EV/EBITDA)	10.71	13.57	18.44	21.55	21.68	25.40	27.91	33.19	30.39	27.40
Enterprise Value to EBIT (EV/EBIT)	12.05	14.95	21.15	25.23	25.95	31.01	34.46	40.07	36.64	32.77
Enterprise Value to NOPAT (EV/NOPAT)	13.84	17.68	25.51	30.82	31.00	36.39	39.32	46.07	42.26	35.96
Enterprise Value to Operating Cash Flow (EV/OCF)	14.98	21.67	26.90	26.59	28.11	26.60	28.55	34.09	32.51	28.66
Enterprise Value to Free Cash Flow (EV/FCFF)	18.44	32.59	43.59	45.97	56.47	43.16	42.86	43.17	46.23	38.68
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.44	-0.47	-0.39	-0.34	-0.34	-0.39	-0.34	-0.37	-0.38	-0.41
Leverage Ratio	1.48	1.46	1.42	1.45	1.42	1.40	1.36	1.36	1.34	1.35
Compound Leverage Factor	1.48	1.48	1.49	1.51	1.49	1.49	1.51	1.39	1.37	1.39
Debt to Total Capital	2.79%	2.00%	1.41%	1.33%	0.95%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.63%	2.00%	1.41%	1.33%	0.95%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	2.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.21%	98.00%	98.59%	98.67%	99.05%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.06	0.05	0.04	0.04	0.03	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.81	-1.03	-0.96	-1.02	-1.18	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.08	0.07	0.06	0.06	0.05	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-1.05	-1.35	-1.33	-1.47	-1.69	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.56	9.59	12.52	12.51	11.69	12.00	13.80	17.07	16.83	15.47
Noncontrolling Interest Sharing Ratio	0.06%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.03	3.03	3.36	3.17	3.28	3.28	3.73	2.80	3.09	2.91
Quick Ratio	1.86	1.86	1.91	1.79	1.83	1.88	2.12	1.49	1.74	1.71
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.17	-177	-178	-59	-85	37	34	211	98	111
Operating Cash Flow to CapEx	697.69%	530.42%	46.66%	363.67%	503.83%	561.12%	16.53%	37.94%	306.50%	452.92%
Free Cash Flow to Firm to Interest Expense	-10.48	-174.52	-180.32	-56.58	-87.98	45.63	51.52	137.73	121.47	188.17
Operating Cash Flow to Interest Expense	348.66	180.69	19.59	136.62	181.05	306.76	11.01	141.22	205.78	480.54
Operating Cash Flow Less CapEx to Interest Expense	298.68	146.63	-22.40	99.05	145.11	252.09	-55.59	-231.00	138.64	374.44
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	0.86	0.86	0.83	0.82	0.77	0.78	0.77	0.77	0.78
Accounts Receivable Turnover	5.87	6.06	6.02	4.86	5.55	5.86	6.03	5.61	5.82	6.31
Inventory Turnover	4.99	4.53	4.08	3.72	3.66	3.59	3.42	3.65	3.73	3.85
Fixed Asset Turnover	8.21	7.83	7.25	6.74	6.43	6.19	5.98	5.95	5.90	5.91
Accounts Payable Turnover	8.27	8.80	8.36	7.28	6.74	7.13	7.69	7.40	6.91	7.44
Days Sales Outstanding (DSO)	62.20	60.27	60.62	75.08	65.75	62.28	60.52	65.03	62.68	57.83
Days Inventory Outstanding (DIO)	73.16	80.54	89.37	98.09	99.66	101.69	106.76	99.98	97.84	94.83
Days Payable Outstanding (DPO)	44.16	41.50	43.69	50.16	54.14	51.22	47.47	49.35	52.80	49.08
Cash Conversion Cycle (CCC)	91.20	99.31	106.30	123.01	111.27	112.75	119.81	115.66	107.72	103.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,432	1,496	1,626	1,655	1,644	1,563	1,660	1,622	1,687	1,601
Invested Capital Turnover	2.48	2.36	2.02	1.83	1.78	1.75	1.62	1.65	1.64	1.78
Increase / (Decrease) in Invested Capital	196	324	258	175	213	67	34	-32	42	38
Enterprise Value (EV)	10,871	12,521	15,863	16,407	14,611	15,568	16,364	22,041	20,754	19,267
Market Capitalization	11,693	13,476	16,687	17,187	15,408	16,505	17,234	23,150	21,970	20,486
Book Value per Share	$14.38	$15.74	$15.70	$15.71	$15.85	$16.52	$16.71	$17.49	$17.79	$17.31
Tangible Book Value per Share	$11.63	$12.81	$12.76	$12.76	$12.99	$13.57	$13.85	$14.73	$15.09	$14.79
Total Capital	2,319	2,501	2,485	2,468	2,465	2,526	2,558	2,731	2,903	2,819
Total Debt	65	50	35	33	24	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-822	-955	-824	-780	-797	-937	-871	-1,108	-1,216	-1,218
Capital Expenditures (CapEx)	39	35	41	39	35	44	44	569	54	62
Debt-free, Cash-free Net Working Capital (DFCFNWC)	664	667	777	778	766	682	762	669	692	592
Debt-free Net Working Capital (DFNWC)	1,440	1,562	1,519	1,487	1,482	1,502	1,511	1,130	1,244	1,192
Net Working Capital (NWC)	1,426	1,512	1,484	1,454	1,459	1,502	1,511	1,130	1,244	1,192
Net Nonoperating Expense (NNE)	4.31	-25	-3.63	-3.74	-0.27	-13	4.29	-7.67	-5.31	2.07
Net Nonoperating Obligations (NNO)	-822	-955	-824	-780	-797	-963	-898	-1,108	-1,216	-1,218
Total Depreciation and Amortization (D&A)	28	2.18	28	27	28	28	28	30	31	27
Debt-free, Cash-free Net Working Capital to Revenue	20.08%	21.15%	25.75%	27.21%	27.97%	25.50%	28.67%	24.76%	25.29%	21.00%
Debt-free Net Working Capital to Revenue	43.53%	49.50%	50.34%	51.97%	54.14%	56.13%	56.84%	41.79%	45.44%	42.26%
Net Working Capital to Revenue	43.09%	47.91%	49.18%	50.83%	53.29%	56.13%	56.84%	41.79%	45.44%	42.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.17	$1.11	$0.54	$0.78	$0.83	$0.76	$0.42	$1.18	$0.89	$0.92
Adjusted Weighted Average Basic Shares Outstanding	156.36M	158.43M	155.90M	154.76M	153.76M	154.31M	153.05M	157.80M	163.00M	159.08M
Adjusted Diluted Earnings per Share	$1.10	$1.04	$0.50	$0.73	$0.78	$0.72	$0.40	$1.14	$0.89	$0.89
Adjusted Weighted Average Diluted Shares Outstanding	166.73M	169.73M	166.31M	164.75M	164.05M	164.30M	162.35M	163.47M	164.25M	163.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	155.76M	156.05M	155.04M	154.01M	152.88M	153.08M	156.11M	163.18M	162.86M	161.72M
Normalized Net Operating Profit after Tax (NOPAT)	189	145	82	122	134	109	72	180	145	153
Normalized NOPAT Margin	22.88%	19.80%	13.22%	17.77%	19.03%	16.27%	12.07%	24.70%	19.61%	20.28%
Pre Tax Income Margin	27.35%	26.68%	15.72%	21.10%	20.50%	20.85%	12.15%	30.06%	21.56%	20.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	289.68	190.00	94.04	133.10	143.69	162.46	99.39	140.01	191.48	260.67
NOPAT to Interest Expense	241.07	144.84	80.95	111.31	132.75	128.35	103.61	116.73	173.69	252.25
EBIT Less CapEx to Interest Expense	239.70	155.93	52.05	95.54	107.75	107.79	32.79	-232.21	124.34	154.57
NOPAT Less CapEx to Interest Expense	191.10	110.78	38.96	73.74	96.82	73.68	37.01	-255.49	106.55	146.15
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.97%	9.74%	10.83%	12.24%	13.53%	15.13%	16.09%	14.34%	14.37%	14.09%
Augmented Payout Ratio	131.99%	114.86%	111.90%	92.17%	82.70%	103.65%	92.02%	54.63%	34.99%	50.70%

Frequently Asked Questions About Teradyne's Financials

When does Teradyne's financial year end?

According to the most recent income statement we have on file, Teradyne's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Teradyne's net income changed over the last 9 years?

Teradyne's net income appears to be on an upward trend, with a most recent value of $542.37 million in 2024, rising from $206.48 million in 2015. The previous period was $448.75 million in 2023. Check out Teradyne's forecast to explore projected trends and price targets.

What is Teradyne's operating income?

Teradyne's total operating income in 2024 was $593.79 million, based on the following breakdown:

Total Gross Profit: $1.65 billion
Total Operating Expenses: $1.06 billion

How has Teradyne revenue changed over the last 9 years?

Over the last 9 years, Teradyne's total revenue changed from $1.64 billion in 2015 to $2.82 billion in 2024, a change of 72.0%.

How much debt does Teradyne have?

Teradyne's total liabilities were at $889.42 million at the end of 2024, a 7.4% decrease from 2023, and a 52.6% increase since 2015.

How much cash does Teradyne have?

In the past 9 years, Teradyne's cash and equivalents has ranged from $264.71 million in 2015 to $1.12 billion in 2021, and is currently $553.35 million as of their latest financial filing in 2024.

How has Teradyne's book value per share changed over the last 9 years?

Over the last 9 years, Teradyne's book value per share changed from 9.57 in 2015 to 17.31 in 2024, a change of 81.0%.

Related Companies

This page (NASDAQ:TER) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teradyne (TER) Financials

Frequently Asked Questions About Teradyne's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teradyne (TER) Financials

Annual Income Statements for Teradyne

Quarterly Income Statements for Teradyne

Annual Cash Flow Statements for Teradyne

Quarterly Cash Flow Statements for Teradyne

Annual Balance Sheets for Teradyne

Quarterly Balance Sheets for Teradyne

Annual Metrics and Ratios for Teradyne

Quarterly Metrics and Ratios for Teradyne

Frequently Asked Questions About Teradyne's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools